however, it may also affect patients with type 2 diabetes ( Case presentation The patient, 36-year old man with new onset of diabetes mellitus, was initially admitted to the Department of Diabetology due to markedly elevated blood glucose levels (277 mg/dl, 15.4 mmol/l), glucosuria, trace amounts of acetone in the urine and with normal arterial blood gas findings
Exp Mol Med 39:106113 Chaudhary P, Marracci GH, Bourdette DN (2006) Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis
doi: 10.3233/JAD-190156 10 KellarDCraftS
There are also a few cautions the FDA notes specific to this drug, including but not limited to: risk of pancreatitis hypoglycemia (low blood sugar) when used in conjunction with certain other drugs renal impairment or kidney failure acute gallbladder disease increased risk of thyroid C-cell tumors The FDA notes that patients who have had, or have family members who have had, medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use liraglutide, nor should individuals who have experienced prior serious hypersensitivity reaction to the drug
